Impact of ivermectin on illness and disability associated with onchocerciasis

Tropical Medicine and International Health

Volumn 9, Issue 4, 2004, Pages

  Tielsch, James M ^a   Beeche, Arlyne ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Disability; Ivermectin; Mectizan; Onchocerciasis

Indexed keywords

IVERMECTIN;

DISABILITY; DISEASE CONTROL; IVERMECTIN; ONCHOCERCIASIS;

CLINICAL FEATURE; CLINICAL TRIAL; COMMUNITY CARE; CORRELATION ANALYSIS; DISABILITY; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; EDEMA; ENDEMIC DISEASE; FILARIASIS; FUTUROLOGY; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HELMINTHIASIS; HUMAN; INFECTION CONTROL; INFESTATION; MEDICAL DOCUMENTATION; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; ORTHOSTATIC HYPOTENSION; PAIN; PARASITE TRANSMISSION; PARASITOSIS; POLITICS; POPULATION RESEARCH; PRURITUS; REVIEW; SCABIES; SIDE EFFECT; SKIN DISEASE; STATISTICAL SIGNIFICANCE; WOLBACHIA;

DEVELOPING COUNTRIES; FILARICIDES; HUMANS; INTERNATIONAL COOPERATION; IVERMECTIN; ONCHOCERCIASIS; ONCHOCERCIASIS, OCULAR; PUBLIC HEALTH;

ONCHOCERCA; ONCHOCERCA VOLVULUS; VERMES; WOLBACHIA;

EID: 2342652216     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2004.01213.x     Document Type: Review

References (99)

1. Abiose A (1998) Onchocercal eye disease and the impact of Mectizan treatment. Annals of Tropical Medicine and Parasitology 92 (Suppl. 1), S11-S22.
2. Albiez EJ, Walter G, Kaiser A et al. (1988) Histological examination of onchocercomata after therapy with ivermectin. Tropical Medicine and Parasitology 39, 93-99.
3. Alley ES, Plaisier AP, Boatin BA et al. (1994) The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 581-584.
4. Amazigo UV, Obono OM, Dadzie KY et al. (2002a) Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Annals of Tropical Medicine and Parasitology 96 (Suppl. 1), S75-S92.
5. Amazigo UV, Brieger WR, Katabarwa M et al. (2002b) The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC). Annals of Tropical Medicine and Parasitology 96 (Suppl. 1), S41-S58.
6. Awadzi K, Dadzie KY, Shulz-Key H, Haddock DRW, Gilles HM & Aziz MA (1985) The chemotherapy of onchocerciasis. X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. Annals of Tropical Medicine and Parasitology 79, 63-78.
7. Awadzi K, Dadzie KY, Shulz-Key H, Gilles HM, Fulford AJ & Aziz MA (1986) The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in Northern Ghana. Annals of Tropical Medicine and Parasitology 80, 433-442.
8. Boatin BA, Hougard JM, Alley ES et al. (1998) The impact of Mectizan on the transmission of onchocerciasis. Annals of Tropical Medicine and Parasitology 92, 47-60.
9. Borsboom GJJM, Boatin BA, Nagelkerke NJD et al. (2003) Impact of ivermectin on onchocerciasis transmission assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West Africa. Filaria Journal 2, 8.
10. Boussinesq M, Chippaux JP, Ernould JC, Quillevere D & Prod'hon J (1995) Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in Northern Cameroon. American Journal of Tropical Medicine and Hygiene 53, 63-67.
11. Brieger WR, Ososanya OO, Kale OO, Oshiname FO & Oke GA (1997) Gender and ethnic differences in onchocercal skin disease in Oyo State, Nigeria. Tropical Medicine and International Health 2, 529-534.
12. Brieger WR, Ishiname FO & Ososanya OO (1998a) Stigma associated with onchocercal skin disease among those affected near the Ofiki and Oyan rivers in western Nigeria. Social Science and Medicine 47, 841-852.
13. Brieger WR, Awedoba AK, Eneanya CI et al. (1998b) The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial. Tropical Medicine and International Health 3, 951-961.
14. Brown KR (1998) Changes in the use profile of Mectizan: 1987-1997. Annals of Tropical Medicine and Parasitology 92 (Suppl. 1), S61-S64.
15. Brown KR & Neu DC (1990) Ivermectin-clinical trials and treatment schedules in onchocerciasis. Review. Acta Leidensia 59, 169-175.
16. Burnham G (1995) Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi. American Journal of Tropical Medicine and Hygiene 52, 270-276.
17. Cao W, Van der Ploeg CPB, Plaisier AP, Van der Sluijs IJ & Lamrnie PJ (1997) Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment. Tropical Medicine and International Health 2, 393-403.
18. Chavasse DC, Post RJ, Lemoh PA & Whitworth JAG (1992) The effect of repeated doses of ivermectin on adult female Onchocerca volvulus in Sierra Leone. Tropical Medicine and Parasitology 43, 256-262.
19. Chavasse DC, Post RJ, Davies JB & Whitworth JAG (1993) Absence of sperm from the seminal receptacle of female Onchocerca volvulus following multiple doses of ivermectin. Tropical Medicine and Parasitology 44, 155-158.
20. Chijioke CP & Okonkwo PO (1992) Adverse events following mass ivermectin therapy for onchocerciasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 284-286.
21. Chippaux JP, Bouchité B, Boussinesq M, Ranque S, Baldet T & Demanou M (1998) Impact of repeated large scale ivermectin treatments on the transmission of Loa loa. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 454-458.
22. Cousens SN, Cassels-Brown A, Murdoch I et al. (1997) Impact of annual dosing with ivermectin on progression of onchocercal visual field loss. Bulletin of the World Health Organization 75, 229-236.
23. Cupp EW, Bernardo MJ, Kiszewski AE et al. (1986) The effects of ivermectin on transmission of Onchocerca volvulus. Science 231, 740-742.
24. Dadzie KY, Bird AC, Awadzi K, Schulz-Key H, Gilles HM & Aziz MA (1987) Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis. British Journal of Ophthalmology 71, 78-85.
25. Dadzie KY, Awadzi K, Bird AC & Schulz-Key H (1989a) Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis. Tropical Medicine and Parasitology 40, 355-360.
26. Dadzie KY, Remme J, Rolland A & Thylefors B (1989b) Ocular onchocerciasis and intensity of infection in the community. II. West African rainforest foci of the vector Simulium yahense. Tropical Medicine and Parasitology 40, 348-354.
27. Dadzie KY, Remme J, Alley ES & de Sole D (1990) Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 103-108.
28. Dadzie KY, Remme J & De Sole G (1991) Changes in ocular onchocerciasis after two rounds of community based ivermectin treatment in a holo-endemic onchocerciasis focus. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 267-271.
29. Das PK, Ramaiah KD, Vanamail P et al. (2001) Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India. Transactions of the Royal Society of Tropical Medicine and Hygiene 95, 336-341.
30. De Sole G & Remme J (1991) Importance of migrants with Onchocerca volvulus in west African river valleys protected by 14 to 15 years of Simulium control. Tropical Medicine and Parasitology 42, 75-78.
31. De Sole G, Remme J, Awadzi K et al. (1989) Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bulletin of the World Health Organization 67, 707-719.
32. Diallo S, Aziz MA, Lariviere M et al. (1986) A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 80, 927-934.
33. Dickson R, Awasthi S, Demellweek C & Williamson P (2002) Anthelmintic drugs for treating worms in children: effects on growth and cognitive performance (Cochrane Review). In: The Cochrane Library, Issue 3. Update Software, Oxford.
34. Duke BOL, Zea-Flores G, Castro J, Cupp EW & Muñoz B (1990) Effects of multiple monthly doses of ivermectin on adult Onchocerca volvulus. American Journal of Tropical Medicine and Hygiene 43, 657-664.
35. Duke BOL, Zea-Flores G, Castro J, Cupp EW & Muñoz B (1991) Comparison of the effects of a single dose and of four six-monthly doses of ivermectin on adult Onchocerca volvulus. American Journal of Tropical Medicine and Hygiene 45, 132-137.
36. Duke BOL, Zea-Flores G, Castro J, Cupp EW & Muñoz B (1992) Effects of three-month doses of ivermectin on adult Onchocerca volvulus. American Journal of Tropical Medicine and Hygiene 46, 189-194.
37. Dunne CL, Malone CJ & Whitworth JAG (1991) A field study of the effects of ivermectin on ectoparasites of man. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 550-551.
38. Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux JP & Boussinesq M (1997) Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350, 18-22.
39. Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue & Duke BOL (2002) Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomized control trial. Lancet 360, 203-210.
40. Ghalib HW, Mackenzie CD, Kron MA, Williams JF, El Khalifa M & El Sheikh H (1987) Severe onchocercal dermatitis in the Ethiopian border region of Sudan. Annals of Tropical Medicine and Parasitology 81, 405-419.
41. Glaziou P, Cartel JL, Alzieu P, Briot C, Moulia-Pelat JP & Vartin PMV (1993) Comparison of ivermectin and benzyl benzoate for treatment of scabies. Tropical Medicine and Parasitology 44, 331-332.
42. Grant W (2000) What is the real target for ivermectin resistance selection in Onchocerca volvulus? Parasitology Today 16, 458-459.
43. Green MS (1989) Epidemiology of scabies. Epidemiologic Reviews 11, 126-150.
44. Greene BM, Taylor HR, Cupp EW et al. (1985) Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. New England Journal of Medicine 313, 133-138.
45. Guderian RH & Shelley AJ (1992) Onchocerciasis in Ecuador: the situation in 1989. Memorias do Instituto Oswaldo Cruz 87, 405-415.
46. Guzzo CA, Furtek Q, Portas AG et al. (2002) Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. Journal of Clinical Pharmacology 42, 1122-1133.
47. Henderson C (1991) Community control of scabies (letter). Lancet 337, 1548.
48. Hoerauf A, Volkmann L, Hamelmann C et al. (2000) Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355, 1242-1243.
49. Hoerauf A, Mand S, Adjei O, Fleischer B & Büttner DW (2001) Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357, 1415-1416.
50. Homeida MMA, Goepp I, Ali M, Hilyer E & Mackenzie CD (1999) Medical achievements under civil war conditions. Lancet 354, 601.
51. Hougard JM, Alley ES, Yaméogo L, Dadzie KY & Boatin BA (2001) Eliminating onchocerciasis after 14 years of vector control: a proved strategy. Journal of Infectious Diseases 184, 497-503.
52. Hougard JM, Yameogo L & Philippon B (2002) Onchocerciasis in West Africa after 2002: a challenge to take up. Parasite 9, 105-111.
53. Katabarwa MN, Habomugisha P & Richards FO Jr (2002) Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997-2000): an evaluation. Annals of Tropical Medicine and Parasitology 96, 61-73.
54. Kazura J, Greenberg J, Perry R, Weil G, Day K & Alpers M (1993) Comparison of single-dose diethymcarbamizine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea. American Journal of Tropical Medicine and Hygiene 49, 804-811.
55. Kennedy MH, Bertocchi I, Hopkins AD & Meredith SE (2002) The effect of 5 years of annual treatment with ivermectin (Mectizane®) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic. Annals of Tropical Medicine and Parasitology 96, 297-307.
56. Kläger SL, Whitworth JAG & Downham MD (1996) Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin. Tropical Medicine and International Health 1, 581-589.
57. Lariviere M, Vingtain P, Aziz M et al. (1985) Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement. Lancet 2, 174-177.
58. Makunde WH, Salum FM, Massaga JJ & Alilio MS (2000) Clinical and parasitological aspects of itching caused by onchocerciasis in Morogoro, Tanzania. Annals of Tropical Medicine and Parasitology 94, 793-799.
59. Masawe AEJ & Nsanzumhgire H (1975) Scabies and other skin diseases in preschool children in Ujamma villages in Tanzania. Tropical and Geographic Medicine 27, 288-294.
60. Meinking TL, Taplin D, Hermida JL, Pardo R & Kerdel FA (1995) The treatment of scabies with ivermectin. New England Journal of Medicine 333, 26-30.
61. Michael E, Bendy DAP & Grenfell BT (1996) Reassessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112, 409-428.
62. Molyneux DH (1995) Onchocerciasis control in West Africa: current status and future of the onchocerciasis control programme. Parasitology Today 11, 399-402.
63. Mukhtar MM, Khier MM, Baraka OZ & Homeida MMA (1998) The burden of Onchocerca volvulus in Sudan. Annals of Tropical Medicine and Parasitology 92 (Suppl. 1), S129-S131.
64. Njoo FL, Belling GAC, Oosting J, Vetter JCM, Stilma JS & Kijlstra A (1993) Concurrent parasitic infections in onchocerciasis and the occurrence of adverse reactions after ivermectin treatment. American Journal of Tropical Medicine and Hygiene 48, 652-657.
65. Ochoa JO, Castro JC, Barrios VM, Juarez EL & Tada I (1997) Successful control of onchocerciasis in San Vincente Pacaya, Guatemala, 1984-1989. Annals of Tropical Medicine and Parasitology 91, 471-479.
66. Ogbuagu KF & Eneanya CI (1998) The multi-centre study of the effect of mectizan treatment on onchocercal skin disease: clinical findings. Annals of Tropical Medicine and Parasitology 92 (Suppl. 1), S139-S145.
67. Pacque MC, Dukuly Z, Greene BM et al. (1989) Community-based treatment of onchocerciasis with ivermectin: acceptability and early reactions. Bulletin of the World Health Organization 67, 721-730.
68. Pacqué M, Muñoz B, Poetschke G, Foose J, Greene BM & Taylor HR (1990a) Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution. Lancet 336, 1486-1489.
69. Pacqué M, Muñoz B, Greene BM et al. (1990b) Safety of and compliance with community-based ivermectin therapy. Lancet 335, 1377-1380.
70. Pacqué M, Muñoz B, Greene BM & Taylor HR (1991a) Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment. Journal of Infectious Diseases 163, 381-385.
71. Pacqué M, Elmets C, Dukuly Z et al. (1991b) Improvement in severe onchocercal skin disease after a single dose of ivermectin. American Journal of Medicine 90, 590-594.
72. Plaisier AP, Alley ES, van Oortmarssen GJ, Boatin BA & Habbema JDF (1997) Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in West Africa. Bulletin of the World Health Organization 75, 237-245.
73. Prod'hon J, Lardeux F, Bain O, Hébrard G & Prud'hom JM (1987) Ivermectine et modalités de la réduction de l'infection des Simulies dans un foyer forestier d'onchocercose humaine. Annales de Parasitologie Humaine et Comparee 62, 590-598.
74. Remme JHF (1998) Onchocerciasis. In: The global epidemiology of infectious diseases (eds CJL Murray & A Lopez) Harvard University Press, Cambridge.
75. Remme J, Baker RHA, De Sole G et al. (1989) A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect of the microfilarial reservoir and the transmission of Onchocerca volvulus. Tropical Medicine and Parasitology 40, 367-374.
76. Remme J, DeSole G, Dadzie KY et al. (1990) Large scale ivermectin distribution and its epidemiological consequences. Acta Leidensia 59, 177-191.
77. Rothova A, Van Der Lelij A, Stilma JS, Wilson WR & Barbe RF (1989) Side-effects of ivermectin in treatment of onchocerciasis. Lancet 1, 1439-1441.
78. Saint André AV, Blackwell NM, Hall LR et al. (2002) The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 295, 1892-1895.
79. Shu EN, Nwadike KI, Onwujekwe EO, Ugwu OC & Okonkwo PO (1999) Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin. East African Medical Journal 76, 320-323.
80. Somo RM, Ngosso A, Dinga JS, Enyong PA & Fobi G (1993) A community-based trial of ivermectin for onchocerciasis control in the forest of southwestern Cameroon: clinical and parasitologic findings after three treatments. American Journal of Tropical Medicine and Hygiene 48, 9-13.
81. Stephenson LS (2001) Optimising the benefits of anthelmintic treatment in children. Paediatric Drugs 3, 495-508.
82. Taylor HR & Greene BM (1989a) The status of ivermectin in the treatment of human onchocerciasis. American Journal of Tropical Medicine and Hygiene 41, 460-466.
83. Taylor MJ & Hoerauf A (1999) Wolbachia bacteria of filarial nematodes. Parasitology Today 15, 437-442.
84. Taylor HR, Semba RD, Newland HS et al. (1989b) Ivermectin treatment of patients with severe ocular onchocerciasis. American Journal of Tropical Medicine and Hygiene 40, 494-500.
85. Taylor HR, Pacqué M, Muñoz B & Greene BM (1990) Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science 250, 116-118.
86. Tchakoute VL, Bronsvoort M, Tanya V, Renz A & Trees AJ (1999) Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi. Parasitology 118, 195-199.
87. Tgaboto SK, Townson S, Titanji WK, Awadzi K, Castro J & Zea-Flores G (1994) Comparison of the sensitivity of different geographical isolates of Onchocerca volvulus microfilariae to ivermectin: effects of exposure to drug on development in the blackfly Simulium ornatum. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 237-241.
88. Thomson MC, Obsomer V, Dunne M, Connor SJ & Molyneux DH (2000) Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa. Lancet 356, 1077-1078.
89. Trpis M, Childs JE, Fryauff DJ et al. (1990) Effect of mass treatment of a human population with ivermectin on transmission of Onchocerca volvulus by Simulium yahense in Liberia, West Africa. American Journal of Tropical Medicine and Hygiene 42, 148-156.
90. Vlassoff C, Weiss M, Ovuga EBL et al. (2000) Gender and the stigma of onchocercal skin disease in Africa. Social Science and Medicine 50, 1353-1368.
91. Wendel K & Rompalo A (2002) Scabies and pediculosis pubis: an update of treatment regimens and general review. Clinical Infectious Diseases 35 (Suppl. 2), S146-S151.
92. White AT, Newland HS, Taylor HR et al. (1987) Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis. Journal of Infectious Diseases 156, 463-470.
93. Whitworth JAG, Gilbert CE, Mabey DM, Maude GH, Morgan D & Taylor DW (1991) Effects of repeated doses of ivermectin on ocular onchocerciasis: community based trial in Sierra Leone. Lancet 338, 1100-1103.
94. Whitworth JAG, Morgan D, Maude GH, Luty AJF & Taylor DW (1992) A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to four doses given at six-monthly intervals. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 277-280.
95. Whitworth JAG, Maude GH & Downham MD (1996) Clinical and parasitological responses after up to 6.5 years of ivermectin treatment for onchocerciasis. Tropical Medicine and International Health 1, 786-793.
96. Winnen M, Plaisier AP, Alley ES et al. (2002) Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bulletin of the World Health Organization 80, 384-390.
97. World Health Organization (1995) The importance of onchocercal skin disease; report of the Pan-African study group on onchocercal skin disease. Document TDR/AFR/RP/95.1. WHO, Geneva.
98. World Health Organization (2002) Annual Report on Lymphatic Filariasis. Document WHO/CDS/CPE/CEE/2002.28. WHO, Geneva.
99. Zea-Flores R, Richards FO Jr, González-Peralta C et al. (1992) Adverse reactions after community treatment of onchocerciasis with ivermectin in Guatemala. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 663-666.